Frontiers in Oncology (Jun 2023)

Corrigendum: Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis

  • Jun-Ning Liu,
  • Ji-Jiang Li,
  • Shu Yan,
  • Guang-Nian Zhang,
  • Peng-Sheng Yi

DOI
https://doi.org/10.3389/fonc.2023.1233247
Journal volume & issue
Vol. 13

Abstract

Read online

No abstracts available.

Keywords